ESERVAL ROCHA JUNIOR
Índice h a partir de 2011
3
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
19 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 19
bookPart Pneumonectomia direita(2023) ROCHA JUNIOR, Eserval; ARAúJO, Pedro Henrique Xavier Nabuco debookPart Plicatura e correção de hérnia diafragmática minimamente invasiva(2023) MACEDO, João Paulo C. de; ROCHA JUNIOR, Eserval; MARIANI, Alessandro Wasum- Lung cancer(2019) CARVALHO, R. L. C. De; LEITE, P. H. C.; REIS, F. P. Dos; JúNIOR, E. R.; TERRA, R. M.Lung carcinoma is the second most common cancer diagnosis by sex, and the number 1 cause of cancer-related mortality. Its association with older age and smoking led to the development of a screening protocol that may lead to improved survival. Most patients are asymptomatic until the disease is in advanced stages. Definitive pathology acquired from biopsy samples and adequate invasive and noninvasive staging are necessary to guide the best treatment strategy, which should be decides in a multidisciplinary way. While pulmonary lobectomy with mediastinal lymphadenectomy is the standard treatment for early stages, radiotherapy and mostly chemotherapy are usually the best options for locally advanced and metastatic disease. © 2020 Elsevier Inc. All rights reserved.
bookPart Segmentectomia posterior lobo superior direito (S2)(2023) ROCHA JUNIOR, Eserval; ARAúJO, Pedro Henrique Xavier Nabuco de; BRAVO, Katherine Astudillo- Risk factors related to pleural empyema after talc slurry pleurodesis(2022) D'AMBROSIO, Paula Duarte; ARAUJO, Pedro Henrique Xavier Nabuco de; ROCHA JUNIOR, Eserval; RAZUK FILHO, Mauro; PEGO-FERNANDES, Paulo Manuel; TERRA, Ricardo MingariniObjective: Empyema is a complication of talc-pleurodesis that may lead to further surgical intervention and death. Therefore, the present study's objective was to identify the risk factors for the development of post-pleurodesis empyema after talc slurry pleurodesis in order to better select patients for this procedure and minimize its morbidity.Methods: Patients with malignant pleural effusion who underwent talc slurry pleurodesis at the present institution from January 2018 to January 2020 were retrospectively analyzed. Post-pleurodesis empyema was defined as pleural infection up to 30 days after pleurodesis. Using Cox regression analysis, significant prognostic factors for the development of empyema were examined.Results: Of the 86 patients identified for inclusion in the study, 62 were women (72%). Their mean age was 56.3 +/- 12.6 years. The median pleural drainage time was 9 days, and 20 patients (23.3%) developed empy-ema. In the univariate analysis, both drainage time (p = 0.038) and the use of antibiotics prior to pleurodesis (p < 0.001) were risk factors for pleural empyema. Multivariate analysis also identified the use of antibiotics as an independent risk factor (Odds Ratio [OR] 9.81; 95% Confidence Interval [95% CI] 2.87-33.54). Although the pulmonary expansion was not associated with empyema in the multivariate analysis, patients with less than 50% pulmonary expansion had a 4.5-times increased risk of empyema (95% CI 0.90-22.86; p = 0.067), and patients with 50-70% pulmonary expansion had a 3.8-times increased risk of empyema (95% CI 0.98-15; p = 0.053) after pleurodesis.Conclusion: The study suggests that antibiotic therapy prior to talc slurry pleurodesis may increase the risk of developing empyema. Furthermore, pleurodesis should be considered with caution in patients with long-duration chest tube placement and incomplete lung expansion.
- Three-dimensional computed tomography reconstruction in the era of digital personalized medicine(2023) ROCHA-JUNIOR, Eserval; PEGO-FERNANDES, Paulo Manuel
- Current morbimortality and one-year survival after pneumonectomy for infectious diseases(2023) D'AMBROSIO, Paula Duarte; MARIANI, Alessandro Wasum; JR, Eserval Rocha; MEDEIROS, Israel Lopes de; OLIVEIRA, Leonardo Cesar Silva; NETO, Antero Gomes; TERRA, Ricardo Mingarini; PEGO-FERNANDES, Paulo ManuelObjective: Identify the one-year survival rate and major complications in patients submitted to pneumonectomy for infectious disease.Methods: Retrospective data from all cases of infectious disease pneumonectomy over the past 10 years were collected from two reference centers. The authors analyzed: patient demographics, etiology, laterality, bronchial stump treatment, presence of previous pulmonary resection, postoperative complications in the first 30 days, the treatment used in pleural complications, and one-year survival rate.Results: 56 procedures were performed. The average age was 44 years, with female predominance (55%). 29 cases were operated on the left side (51%) and the most frequent etiology was post-tuberculosis (51.8%). The overall incidence of complications was 28.6% and the most common was empyema (19.2%). Among empyema cases, 36.3% required pleurostomy, 27.3% required pleuroscopy and 36.3% underwent thoracoplasty for treatment. Bronchial stump fistula was observed in 10.7% of cases. From all cases, 16.1% were completion pneumonectomies and 62.5% of these had some complication, a significantly higher incidence than patients without previous surgery (p = 0.0187). 30-day in-hospital mortality was (7.1%) with 52 cases (92.9%) and 1-year survival. The causes of death were massive postoperative bleeding (1 case) and sepsis (3 cases).Conclusions: Pneumonectomy for benign disease is a high-risk procedure performed for a variety of indications. While morbidity is often significant, once the perioperative risk has passed, the one-year survival rate can be very satisfying in selected patients with benign disease.
- Robotic lung resection: a narrative review of the current role on primary lung cancer treatment(2022) ROCHA JUNIOR, Eserval; TERRA, Ricardo MingariniBackground and Objective: Robotic-assisted thoracic surgery (RATS) has increasingly been applied to primary lung cancer treatment. Given the many facilities provided by the robotic platform in the manipulation of tissues and precision of movements, there is continuous enquiring about its contribution to the improvement of surgical outcomes. Also, the possibility to perform complex resections in a minimally invasive way using a robotic approach starts to become possible as the centers' learning curve expands. We propose to perform a review of the current status of robotic surgery for lung cancer focusing on key frontier points: sublobar resections, quality of lymphadenectomy, complex resections, postoperative outcomes, and innovative technologies to arrive. Methods: We performed a narrative review of the literature aggregating the most current references available in English. Key Content and Findings: According to the current data, the flourishing of the robotic platform seems to be in line with the spread of sublobar resections. The technological benefits inherent to the platform, also seem to promote an increase in the quality of lymphadenectomy and a shorter learning curve when compared to video-assisted thoracic surgery (VATS) with equivalent oncological results. Its application in complex resections such as bronchial sleeve already presents consistent results and new technology acquisitions such as three-dimensional reconstructions, augmented reality and artificial intelligence tend to be implemented collaborating with the digitization of surgery. Conclusions: Robotic surgery for lung cancer resection is at least equivalent to the VATS approach considering the currently available literature. However, more practice time and prospective clinical trials are needed to identify more exact benefits.
- Robotic Lung Volume Reduction Surgery With Extracorporeal Membrane Oxygenation(2022) ROCHA JUNIOR, Eserval; TERRA, Ricardo Mingarini; CARDOSO, Paulo Francisco Guerreiro; ABDALLA, Luis Gustavo; FERNANDES, Lucas Matos; ALBUQUERQUE, Andre Luis Pereira de; BARRA, Silvia Maria Pinella Helaehil; PEGO-FERNANDES, Paulo ManuelLobectomy for consolidation of failed endoscopic lung volume reduction for emphysema has been reported in selected patients with favorable results but with considerable morbidity. The challenging issues in such patients are frailty caused by severe emphysema itself, poor tolerance to single-lung ventilation, target lobe hyperinflation, and inability to use gas inflation for the minimally invasive resection. Careful planning, including use of a robotic platform and extracorporeal membrane oxygenation support, can circumvent such difficulties and ensure a safe, minimally invasive resection in the high-risk emphysematous patient. (Ann Thorac Surg 2022;114:e351-e354) (c) 2022 by The Society of Thoracic Surgeons
conferenceObject Nodal Upstaging Comparison of Open, Video-Assisted Thoracoscopic, and Robotic Lung Resections Form Non-Small Cell Lung Cancer(2021) TERRA, R.; VEGA, A. Dela; LAURICELLA, L.; ROCHA JR., E.; LIMA, L.; CREMONESE, M.; PEGO-FERNANDES, P.